Vestcor Inc’s Amneal Pharmaceuticals AMRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$891K Buy
71,721
+61,189
+581% +$822K 0.02% 536
2025
Q4
$133K Sell
10,532
-12,874
-55% -$147K ﹤0.01% 1023
2025
Q3
$234K Buy
23,406
+16,365
+232% +$147K 0.01% 946
2025
Q2
$57K Buy
+7,041
New +$53.1K ﹤0.01% 1098
2025
Q1
Sell
-31,393
Closed -$249K 1163
2024
Q4
$249K Hold
31,393
0.01% 926
2024
Q3
$261K Hold
31,393
0.01% 901
2024
Q2
$199K Hold
31,393
0.01% 945
2024
Q1
$190K Buy
31,393
+14,815
+89% +$83.5K 0.01% 981
2023
Q4
$101K Buy
+16,578
New +$73.8K ﹤0.01% 1087

Other funds holding AMRX

Vestcor Inc's AMRX Position: Q1 2026 in Review

Vestcor Inc increased its Amneal Pharmaceuticals (AMRX) stake by 581% in Q1 2026, buying an estimated $822K and bringing the position to 71,721 shares worth $891K. The position accounts for 0.02% of the portfolio, ranked #536.

Vestcor Inc first reported a position in AMRX in Q4 2023 and has held it in 9 quarters since. 315 funds tracked by Wall St. Rank hold AMRX as of Q1 2026.

  • Vestcor Inc held 71,721 shares of Amneal Pharmaceuticals worth $891K as of Q1 2026.
  • Vestcor Inc bought 61,189 Amneal Pharmaceuticals shares in Q1 2026, an estimated $822K.
  • Amneal Pharmaceuticals made up 0.02% of Vestcor Inc's portfolio in Q1 2026, its #536 holding.
  • Vestcor Inc first reported a position in Amneal Pharmaceuticals in Q4 2023 and has held it in 9 quarters since.
  • 315 funds tracked by Wall St. Rank held Amneal Pharmaceuticals as of Q1 2026.

Based on Vestcor Inc's 13F filing for Q1 2026, filed 12 May 2026.